Market Overview
The global pet blood tester market was valued at USD 728 million in 2024 and is projected to reach USD 995 million by 2031, exhibiting a CAGR of 4.7% during the forecast period. This growth is fueled by the expanding pet care industry, where diagnostic tools are becoming increasingly vital for veterinary healthcare.
Pet blood testers are specialized medical devices designed to analyze blood samples from companion animals like dogs and cats. These instruments measure key parameters such as blood cell counts, glucose levels, and biochemical markers, enabling veterinarians to diagnose conditions ranging from infections to organ dysfunction. The market offers both portable handheld units for point-of-care testing and benchtop analyzers for comprehensive laboratory analysis.
USD 728 million in 2024
2032 USD 995 million by 2031
of 4.7%
Portable Type Dominates the Market Due to its Convenience and Flexibility in Veterinary
Settings
The market is segmented based on type into:
Portable Type
Subtypes: Handheld analyzers, compact bench-top models, and others
Desktop Type
Subtypes: Semi-automated analyzers, fully automated systems, and others
Multi-Parameter Analyzers
By Application
Pet Hospitals Lead Market Adoption Owing to Increased Pet Healthcare Expenditure
The market is segmented based on application into:
Pet Hospitals Veterinary Stations Research Institutions
Pet Breeding Centers
Our Key Players
BMV Technology (China)
CHISON Medical Imaging (China)
DRE Veterinary (U.S.)
Eickemeyer Veterinary Equipment (Germany)
Shenzhen Bestman Instrument (China)
Well.D Medical (China)
SonoScape (China)
https://www.24lifesciences.com
